🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Microvascular Monitoring in Circulatory Shock and Sepsis (MiMICSS)

Recruitingn/aAges 18 Years - anyAllUniversity of Manitoba
NCT05985525 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Investigation of the feasibility of using near-infrared spectroscopy (NIRS) to monitor microvascular function in critically ill patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Admitted to ICU * Receiving invasive mechanical ventilation Exclusion Criteria: * Body Mass Index \>40 * More than 24 hours has elapsed since ICU admission * Death is deemed to be imminent and inevitable during the next 24 hours * Known allergy to the textile components of the device * Significant clinical jaundice, ecchymosis * COVID positive microbiological result * The treating clinician believes that participation in the domain would not be in the best interests of the patient * Consent declined from patient or authorized third party
💊

What it tests

  • Skeletal muscle and cerebral NIRS (research device)
📍

Where

1 site
Health Sciences Centre Winnipeg
Winnipeg, Canada
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy